Cytokinetics, Inc. (CYTK)
69.97
+1.71
(+2.51%)
USD |
NASDAQ |
Feb 24, 16:00
69.10
-0.87
(-1.24%)
After-Hours: 19:38
Cytokinetics Research and Development Expense (Quarterly) : 96.55M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 2.561B |
| Molina Healthcare, Inc. | -- |
| Lifecore Biomedical, Inc. | 1.963M |
| Fortrea Holdings, Inc. | -- |
| Ionis Pharmaceuticals, Inc. | 217.13M |